| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
100,000,000 |
| Market
Cap: |
220.00(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.04 - $5.1 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile MaxCyte is a commercial cell engineering company engaged on providing enabling platform technologies to improve cell-based research and development as well as cell therapeutic discovery, development and commercialization. Co.'s ExPERT platform, which is based on its Flow Electroporation technology, has been designed to address this cell therapy market and can be utilized across the continuum of the cell therapy sector, from discovery and development through commercialization of cell-based medicines. The ExPERT family of products includes: three instruments, which Co. calls the ATx, STx and GTx.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
100,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$489,065 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
15,969 |
243,702 |
512,035 |
| Total Sell Value |
$0 |
$61,240 |
$964,604 |
$2,254,540 |
| Total People Sold |
0 |
4 |
6 |
7 |
| Total Sell Transactions |
0 |
5 |
21 |
40 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Douglas Richard |
|
• • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
29,210 |
150,577 |
|
- |
|
| Johnston John Joseph |
|
• • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
29,210 |
171,160 |
|
- |
|
| Al-Wakeel Yasir B. |
|
• • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
29,210 |
50,577 |
|
- |
|
| Balthrop Patrick J |
|
• • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
29,210 |
50,577 |
|
- |
|
| Brooke William W |
|
• • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
29,210 |
100,879 |
|
- |
|
| Hemrajani Rekha |
|
• • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
29,210 |
50,577 |
|
- |
|
| Erck Stanley C |
|
• • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
29,210 |
298,328 |
|
- |
|
| Collins Cynthia |
|
• • – |
2025-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
29,210 |
80,889 |
|
- |
|
| Swirsky Douglas J |
CHIEF FINANCIAL OFFICER |
• • – |
2025-03-18 |
4 |
S |
$3.18 |
$22,061 |
D/D |
(6,939) |
111,811 |
|
31% |
|
| Soleymannezhad Ali |
Chief Commercial Officer |
• • – |
2025-03-18 |
4 |
S |
$3.18 |
$3,850 |
D/D |
(1,211) |
59,439 |
|
31% |
|
| Sandoval David I. |
GENERAL COUNSEL |
• • – |
2025-03-18 |
4 |
S |
$3.18 |
$1,122 |
D/D |
(353) |
64,219 |
|
31% |
|
| Swirsky Douglas J |
CHIEF FINANCIAL OFFICER |
• • – |
2025-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
118,750 |
|
- |
|
| Soleymannezhad Ali |
Chief Commercial Officer |
• • – |
2025-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
34,625 |
60,650 |
|
- |
|
| Sandoval David I. |
GENERAL COUNSEL |
• • – |
2025-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,125 |
64,572 |
|
- |
|
| Johnston John Joseph |
|
– • – |
2025-01-27 |
4 |
AS |
$4.65 |
$13,935 |
D/D |
(3,000) |
141,950 |
|
-52% |
|
| Johnston John Joseph |
|
– • – |
2025-01-27 |
4 |
OE |
$2.93 |
$8,796 |
D/D |
3,000 |
144,950 |
|
- |
|
| Sandoval David I. |
GENERAL COUNSEL |
• • – |
2025-01-13 |
4 |
S |
$4.54 |
$20,272 |
D/D |
(4,466) |
41,447 |
|
54% |
|
| Johnston John Joseph |
|
– • – |
2024-12-26 |
4 |
AS |
$4.01 |
$12,021 |
D/D |
(3,000) |
141,950 |
|
-40% |
|
| Johnston John Joseph |
|
– • – |
2024-12-26 |
4 |
OE |
$2.93 |
$8,796 |
D/D |
3,000 |
144,950 |
|
- |
|
| Johnston John Joseph |
|
– • – |
2024-12-09 |
4 |
AS |
$3.79 |
$9,459 |
D/D |
(2,495) |
141,950 |
|
-35% |
|
| Johnston John Joseph |
|
– • – |
2024-12-09 |
4 |
OE |
$1.64 |
$5,863 |
D/D |
2,495 |
144,445 |
|
- |
|
| Johnston John Joseph |
|
– • – |
2024-12-06 |
4 |
AS |
$3.70 |
$1,869 |
D/D |
(505) |
141,950 |
|
-29% |
|
| Johnston John Joseph |
|
– • – |
2024-12-06 |
4 |
OE |
$2.93 |
$1,478 |
D/D |
505 |
142,455 |
|
- |
|
| Erck Stanley C |
|
– • – |
2024-11-01 |
4 |
AS |
$3.72 |
$177,403 |
D/D |
(47,689) |
269,118 |
|
-14% |
|
| Erck Stanley C |
|
– • – |
2024-11-01 |
4 |
OE |
$0.04 |
$1,908 |
D/D |
47,689 |
316,807 |
|
- |
|
183 Records found
|
|
Page 1 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.10 (4.35%) 
